4f1l: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
Line 1: Line 1:


==Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z)==
==Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z)==
<StructureSection load='4f1l' size='340' side='right' caption='[[4f1l]], [[Resolution|resolution]] 1.90&Aring;' scene=''>
<StructureSection load='4f1l' size='340' side='right'caption='[[4f1l]], [[Resolution|resolution]] 1.90&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[4f1l]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F1L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4F1L FirstGlance]. <br>
<table><tr><td colspan='2'>[[4f1l]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F1L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4F1L FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0RY:(2Z)-4-[(3-CARBAMOYLPHENYL)AMINO]-4-OXOBUT-2-ENOIC+ACID'>0RY</scene>, <scene name='pdbligand=NO3:NITRATE+ION'>NO3</scene></td></tr>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0RY:(2Z)-4-[(3-CARBAMOYLPHENYL)AMINO]-4-OXOBUT-2-ENOIC+ACID'>0RY</scene>, <scene name='pdbligand=NO3:NITRATE+ION'>NO3</scene></td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4f1q|4f1q]], [[3smi|3smi]], [[3smj|3smj]], [[3se2|3se2]], [[3goy|3goy]]</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4f1l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f1l OCA], [https://pdbe.org/4f1l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4f1l RCSB], [https://www.ebi.ac.uk/pdbsum/4f1l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4f1l ProSAT]</span></td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">BAL2, KIAA1268, PARP14 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4f1l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4f1l OCA], [http://pdbe.org/4f1l PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4f1l RCSB], [http://www.ebi.ac.uk/pdbsum/4f1l PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4f1l ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/PAR14_HUMAN PAR14_HUMAN]] Enhances STAT6-dependent transcription (By similarity). Has ADP-ribosyltransferase activity.  
[https://www.uniprot.org/uniprot/PAR14_HUMAN PAR14_HUMAN] Enhances STAT6-dependent transcription (By similarity). Has ADP-ribosyltransferase activity.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 23: Line 20:


==See Also==
==See Also==
*[[Poly (ADP-ribose) polymerase|Poly (ADP-ribose) polymerase]]
*[[Poly(ADP-ribose) polymerase 3D structures|Poly(ADP-ribose) polymerase 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Homo sapiens]]
[[Category: Andersson, C D]]
[[Category: Large Structures]]
[[Category: Ekblad, T]]
[[Category: Andersson CD]]
[[Category: Elofsson, M]]
[[Category: Ekblad T]]
[[Category: Karlberg, T]]
[[Category: Elofsson M]]
[[Category: Lindgren, A]]
[[Category: Karlberg T]]
[[Category: Linusson, A]]
[[Category: Lindgren A]]
[[Category: Schuler, H]]
[[Category: Linusson A]]
[[Category: Spjut, S]]
[[Category: Schuler H]]
[[Category: Thorsell, A G]]
[[Category: Spjut S]]
[[Category: Weigelt, J]]
[[Category: Thorsell AG]]
[[Category: Adp-ribose]]
[[Category: Weigelt J]]
[[Category: Adp-ribosylation]]
[[Category: Artd transferase domain]]
[[Category: Artd8]]
[[Category: Bal2]]
[[Category: Nad]]
[[Category: Parp14]]
[[Category: Transferase-transferase inhibitor complex]]

Revision as of 04:28, 7 October 2022

Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z)

4f1l, resolution 1.90Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=4f1l&oldid=3642507"